Not applicableLooking for participantsNCT05006131What this trial is testingPancreatic Cancer Screening for At-risk IndividualsWho this might be right forPancreatic Cancer, Adult Beth Israel Deaconess Medical Center 1,395
Testing effectiveness (Phase 2)Looking for participantsNCT06584227What this trial is testingAdebrelimab and Chidamide for Pancreatic CancerWho this might be right forPancreatic Cancer, Adult Liu Xiufeng 45
Early research (Phase 1)Study completedNCT00981162What this trial is testingSorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine HydrochlorideWho this might be right forAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more Roswell Park Cancer Institute 12
Not applicableActive Not RecruitingNCT07243288What this trial is testingEvaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line ChemotherapyWho this might be right forPancreatic CancerMeSH Term-Pancreatic Cancer, Adult) Assistance Publique - Hôpitaux de Paris 400
Not applicableStudy completedNCT05438927What this trial is testingEarly Supportive Care and Nutritional Support in Adults With Pancreatic CancerWho this might be right forPancreatic Cancer H. Lee Moffitt Cancer Center and Research Institute 50
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Early research (Phase 1)Study completedNCT01924260What this trial is testingAlisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic CancerWho this might be right forAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+3 more Edward Kim 26
Early research (Phase 1)Looking for participantsNCT05969041What this trial is testingStudy of MT-302 in Adults With Advanced or Metastatic Epithelial TumorsWho this might be right forEpithelial Tumors, Malignant Myeloid Therapeutics 48
Early research (Phase 1)Study completedNCT00987766What this trial is testingGemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+3 more Vanderbilt-Ingram Cancer Center 28
Post-approval studies (Phase 4)WithdrawnNCT04315311What this trial is testingStudy Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic CancerWho this might be right forExocrine Pancreatic Insufficiency (EPI) AbbVie
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Looking for participantsNCT07488676What this trial is testingASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsWho this might be right forGastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT06005493What this trial is testingStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid TumorsWho this might be right forGastric CancerGastro-esophageal Junction CancerPancreatic Ductal Adenocarcinoma+1 more AstraZeneca 280
Large-scale testing (Phase 3)Looking for participantsNCT05786716What this trial is testingDETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsWho this might be right forHaematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more Cancer Research UK 30
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)UnknownNCT00553683What this trial is testingCyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerWho this might be right forBreast CancerColorectal CancerGastric Cancer+5 more Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT00019786What this trial is testingIsolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesWho this might be right forColorectal CancerIslet Cell TumorLiver Cancer+2 more National Institutes of Health Clinical Center (CC) 67
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT02333188What this trial is testingGenetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAdenocarcinoma of Unknown PrimaryAdult CholangiocarcinomaGallbladder Carcinoma+14 more University of Chicago 50
Testing effectiveness (Phase 2)Looking for participantsNCT06906562What this trial is testingA Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic AlterationsWho this might be right forAdvanced Pancreatic CarcinomaMetastatic Pancreatic CarcinomaStage II Pancreatic Cancer AJCC v8+2 more Sameek Roychowdhury 40